Table 1. Scopolamine Response vs. Remission (Rates Based on MADRS)a.
Diagnosis | Response (≥50% Improvement) | Remission (Mean of Final Two Sessions ≤10) |
---|---|---|
MDD | ||
n/ntotal (%) | 26/38 (68) | 18/38 (47) |
BD | ||
n/ntotal (%) | 10/15 (67) | 9/15 (60) |
BD, bipolar disorder; MADRS, Montgomery-Åsberg Depression Rating Scale; MDD, major depressive disorder.
One BD and no MDD subjects met response criteria to placebo.